Friday | 5 December, 2008
Australian Biotechnology News

Stories about: Bruker Daltonics

  • +

    HealthLinx and Cryptome embark on a future together 21/02/2006 10:21:58

    The first merger of 2006 has created new opportunities in the hot field of theranostics. Ruth Beran talks with its architects about the merged company and its future plans.
  • +

    Cryptome to acquire HealthLinx 17/11/2005 14:22:24

    Melbourne biopharma Cryptome Pharmaceuticals (ASX:CRP) has entered a non-binding terms sheet to acquire HealthLinx, a privately-held diagnostics specialist with lead candidates targeting ovarian cancer and complications in pregnancy.
  • +

    Melbourne's HealthLinx signs assay deal with Bruker 25/05/2005 14:45:02

    Melbourne-based health-management house HealthLinx has signed a collaboration agreement with US clinical proteomics company Bruker Daltonics to develop a multiplex, in vitro diagnostic (IVD) assay for ovarian cancer.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links